(Q38056415)

27 August 2017

title

The role and clinical implications of microRNAs in hepatocellular carcinoma (English)

1 reference

27 August 2017

1 reference

Xue Zhao

1

1 reference

27 August 2017

Zhen Yang

2

1 reference

27 August 2017

Guangbing Li

3

1 reference

27 August 2017

Dongkai Li

4

1 reference

27 August 2017

Yi Zhao

5

1 reference

27 August 2017

Yan Wu

6

1 reference

27 August 2017

Simon C Robson

7

1 reference

27 August 2017

Lian He

8

1 reference

27 August 2017

Yiyao Xu

9

1 reference

27 August 2017

Ruoyu Miao

10

1 reference

27 August 2017

Haitao Zhao

11

1 reference

27 August 2017

language of work or name

1 reference

31 October 2012

1 reference

Science in China. Series C: Life Sciences

27 August 2017

published in

1 reference

27 August 2017

volume

55

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

906-919

1 reference

Reports from the 2010 Clinical and Translational Cancer Research Think Tank meeting: design strategies for personalized therapy trials

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Tyrosine kinase inhibitors to treat liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Pericentral activity of alpha-fetoprotein enhancer 3 and glutamine synthetase upstream enhancer in the adult liver are regulated by β-catenin in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA silencing in primates: towards development of novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Cardinal roles of miRNA in cardiac development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNAs in neural cell development and brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Marek’s disease virus-encoded microRNAs: genomics, expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNAs in tomato plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Micro-RNAs in gastrointestinal and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

The miRNA expression profile of the uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Identification of Pns12 as the second silencing suppressor of Rice gall dwarf virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Effects of hepatitis B virus X protein on the development of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

antiCODE: a natural sense-antisense transcripts database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNAs and Their Therapeutic Potential for Human Diseases: MicroRNAs, miR-143 and -145, Function as Anti-oncomirs and the Application of Chemically Modified miR-143 as an Anti-cancer Drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Retracted: Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Regulation of neuronal survival by the serine-threonine protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Hepatitis C virus core protein: an update on its molecular biology, cellular functions and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Interferon modulation of cellular microRNAs as an antiviral mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells: insights from studies with small interfering RNAS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Replication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

The Hepatitis C Virus RNA 3'-Untranslated Region Strongly Enhances Translation Directed by the Internal Ribosome Entry Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

The hepatitis C virus 3'-untranslated region or a poly(A) tract promote efficient translation subsequent to the initiation phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Nuclear factors are involved in hepatitis C virus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Activation of hepatitis C virus translation by a liver-specific microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

A novel function for a micro RNA: negative regulators can do positive for the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

dbDEMC: a database of differentially expressed miRNAs in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Epigenetic changes in virus-associated human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Prediction and identification of tumor-specific noncoding RNAs from human UniGene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Progress, challenges and new concepts in microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

CD44 is required for two consecutive steps in HGF/c-Met signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Diagnostic and therapeutic management of cancer of an unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

A mammalian microRNA expression atlas based on small RNA library sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

ADAM9 as a potential target molecule in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

RNAi-mediated ADAM9 gene silencing inhibits metastasis of adenoid cystic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

miR2Disease: a manually curated database for microRNA deregulation in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

S-MED: sarcoma microRNA expression database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

microRNA-181b targets MLK2 in HL-60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

KEGG for linking genomes to life and the environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Overview of available methods for diverse RNA-Seq data analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Identification and functional annotation of novel microRNAs in the proximal sciatic nerve after sciatic nerve transection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Detection of foreign RNA: implications for RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Strategies for silencing human disease using RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2, -9, FAK, Rho A and Rock-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

Long-term ex vivo monitoring of in vivo microRNA activity in liver using a secreted luciferase sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-012-4384-X

10.1007/S11427-012-4384-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1047034036

0 references

1 reference